Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.3.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.15.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GJ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used